Analyst Ratings for Avita Medical Ltd. (RCEL)
RCEL Rating Summary
RCEL Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$28.25 (+231.6%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 84%
Avg. $ Target:
$28.25 (+231.6%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 84%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/11/2024 | BTIG | Ryan Zimmerman | Downgrade | Neutral (Buy) |
N/A (N/A) |
14.44 (8.52) |
-41% | Details |
| 6/27/2023 | Cantor Fitzgerald » Updated 2/23/2024 |
Ross Osborne | New Coverage | Overweight (N/A) |
25.00 (22.00) |
15.71 (8.52) |
-45.77% | Details |
 |
||||||||
|
||||||||
|
||||||||
